Abcellera Biologics Inc (ABCL) — Long-term Investment Intensity
Abcellera Biologics Inc (ABCL) has a Long-term Investment Intensity of 5.0% as of March 2026. Long-term investments of $65.31 Million represent 5.0% of total assets of $1.31 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Abcellera Biologics Inc (ABCL) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Abcellera Biologics Inc Long-term Investment Intensity (2020–2025)
This chart shows how Abcellera Biologics Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2020 to 2025. As of March 2026, the intensity stands at 5.0%, reflecting long-term investments of $65.31 Million against total assets of $1.31 Billion USD. Explore Abcellera Biologics Inc (ABCL) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Abcellera Biologics Inc (2020–2025)
The table below presents the year-by-year Long-term Investment Intensity for Abcellera Biologics Inc from 2020 to 2025, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see ABCL market cap.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 4.6% | $62.58 Million | $1.36 Billion | ▼ -1.4 pp |
| 2024 | 6.0% | $82.30 Million | $1.36 Billion | ▲ +1.6 pp |
| 2023 | 4.4% | $65.94 Million | $1.49 Billion | ▼ -0.3 pp |
| 2022 | 4.7% | $72.52 Million | $1.54 Billion | ▲ +0.9 pp |
| 2021 | 3.8% | $50.31 Million | $1.32 Billion | ▲ +1.9 pp |
| 2020 | 1.9% | $19.25 Million | $1.01 Billion | — |